Neurosciences articles for France

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 127

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.13
Enhancing Thrombolysis Safety in Post-Acute Ischemic Stroke with Tissue Plasminogen Activator-Associated Microparticles 0.13
1 0.05
Multiple Health Care Encounters Prior to Diagnosis of Cerebral Venous Thrombosis 0.05
20 6.84
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion 0.02
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis 0.03
Supratentorial Brain Lesions in Unconscious Patients Map to a Common Human Brain Circuit 0.07
Functional Segregation of Epileptogenicity within the Human Amygdala 1.00
Refining Detection of Subclinical Epileptiform Activity in Alzheimer's Disease: A Case–Control Study and Call for a Consensus 1.00
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.01
Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease 0.06
Age-Related Differences in the Association between REM Sleep and the Polygenic Risk for Parkinson's Disease 0.08
Thrombectomy versus Medical Management for Pediatric Acute Ischemic Stroke Due to Isolated M2 Occlusion: A Multicenter Cohort Study 0.16
Aneurysm Wall Enhancement and Probability of Instability in Unruptured Intracranial Aneurysms: A Long‐Term Follow‐Up Study 0.20
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.06
Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study 0.29
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial 0.06
iHCN2/i‐Associated Neurodevelopmental Disorders: Data from Patients and iXenopus/i Cell Models 0.36
Disease Progression in Multiple System Atrophy: The scpASPIRE/scp Multi‐Modal Biomarker Study 0.96
Subthalamic Electrophysiological Mapping of Gait Initiation Dynamics and Freezing in Parkinson's Disease 0.96
Mapping Postictal Aphasia through Signal Complexity: A Stereo‐Electroencephalography Study 1.00
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis 0.01
Deep Brain Stimulation for scpiVPS16/i/scp‐Related Dystonia: A Multicenter Study 0.05
Intravenous Thrombolysis Use before Inter‐Facility Transfer for Thrombectomy: Association with Efficacy and Safety Outcomes 0.47
2 1.03
An immunometabolic signature of major depressive disorder in systemic lupus erythematosus 1.00
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment 0.03
13 5.90
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis 1.00
Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness 0.44
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia 0.06
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 0.01
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients 0.01
Intra-putaminal muscarinic receptor agonist infusion induces a dystonic phenotype in non-human primate 1.00
Brain atrophy patterns in anti-IgLON5 disease 0.09
Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson’s disease 0.06
Serotonergic dysfunction in patients with impulse control disorders in Parkinson’s disease 1.00
Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan 0.18
Pure autonomic failure: a natural history study of the Queen Square cohort 0.05
Linking polygenic risk scores to dopaminergic neuron loss using neuromelanin-sensitive imaging 1.00
Functional contribution of astrocytic Kir4.1 channels to spasticity after spinal cord injury 1.00
2 0.41
Astrocytes functionally integrate multiple synapses via specialized leaflet domains 0.31
In vivo prime editing rescues alternating hemiplegia of childhood in mice 0.11
1 0.22
Structural insights into copper and zinc binding to tau protein and the impact of metal binding on amyloid aggregation 0.22
4 2.97
Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring. 0.06
Explainable Machine Learning for Coma Outcome Prediction Based on Structural and Functional Brain MRI. 0.92
Effect of Paracetamol on Cerebral Temperature in Febrile Brain-Injured Patients. The NEUROTHERM Study: A Randomized Controlled Pharmacodynamic Trial. 1.00
Added Value of Late Auditory Evoked Potentials in the Multimodal Prognostication of Patients With Disorders of Consciousness. 1.00
2 0.65
Nocturnal ants navigate using a time-compensated lunar compass 0.25
Functional organization of voice patches in marmosets and cross-species comparisons with macaques and humans 0.40
1 0.08
Exposure to low-dose ionizing radiation and dementia mortality in Canadian nuclear power plant workers 0.08
1 0.25
Transcriptional modulation unique to vulnerable motor neurons predicts ALS across species and SOD1 mutations 0.25
3 1.27
Remodeling of skull bone channels regulates immune infiltration into the meninges during neuroinflammation 1.00
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis 0.15
Sensory neurons shape local macrophage identity via TGF-β signaling 0.12
1 0.17
Long-term fasting-induced parasympathetic and sympathetic autonomic nervous system modulation in a subgroup of the GENESIS study 0.17
3 1.07
Disruption of CSF-1 receptor-mediated metal ion homeostasis in the murine brain promotes neurodegenerative disease 0.05
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy 0.02
MuSK cysteine-rich domain antibodies are pathogenic in a mouse model of autoimmune myasthenia gravis 1.00
1 0.05
Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease 0.05
3 0.66
Motoneurons inhibitory synapses homeostatically respond to neuronal activity and modulate Amyotrophic Lateral Sclerosis pathogenesis 0.18
Toward Unified Biomarkers for Focal Epilepsy 0.34
Neural responses underlying interaural time difference discrimination as a function of sensory reliability in the barn owl 0.14
1 0.95
Risk models of cancer-related cognitive complaints among early breast cancer survivors in the CANTO cohort 0.95
3 1.99
The short-chain fatty acid butyrate prevents gut-brain amyloid-β pathology and neuroinflammation in an Alzheimer mouse model 1.00
Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI study 0.08
The alpha7 nicotinic acetylcholine receptor mediates network dysfunction in a mouse model of local amyloid pathology 0.91
3 1.53
Synthetic α-synuclein fibrils replicate in mice causing MSA-like pathology 0.64
Lymphoid gene expression supports neuroprotective microglia function 0.01
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction 0.88
1 0.07
Endoplasmic reticulum–mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis 0.07
1 0.19
Tau phosphorylation impedes functionality of protective tau envelopes 0.19
17 3.85
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality 0.09
Thyrotropin-releasing hormone neurons of different hypothalamic nuclei increase energy expenditure 0.05
Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/PS1dE9 Alzheimer’s disease model 1.00
Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer’s disease 0.02
Spinal cord stimulation therapy for gait impairment in Parkinson’s disease: a double-blinded, randomised feasibility trial with an open extension 0.05
TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism 0.01
Identification of a thermogenic target in the dorsal raphe nucleus for weight management in mice 0.03
Reduced Ventral Tegmental Area GABA neuron output contributes to hyperactivity in the activity-based anorexia model in female mice 0.04
Prime editing of the β adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease 0.10
Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoids 0.14
Estrogen-related receptor gene expression associates with sex differences in cortical atrophy in isolated REM sleep behavior disorder 0.22
Synthetic chaperone based on Hsp90-Tau interaction inhibits Tau aggregation and rescues physiological Tau-Microtubule interaction 0.36
Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model 0.01
Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats 0.15
Hamsters with long COVID present distinct transcriptomic profiles associated with neurodegenerative processes in brainstem 1.00
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease 0.06
In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis 0.52
1 0.03
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.03
2 0.13
A transcriptomic microglia taxonomy across mouse and human pathologies 0.01
Distinct origins and niches determine the cellular responsiveness of CNS macrophages after repopulation 0.12
2 0.32
Microbiome signature of Parkinson’s disease in healthy and genetically at-risk individuals 0.20
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.11
5 0.84
Sleep-dependent infraslow rhythms are evolutionarily conserved across reptiles and mammals 0.64
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease 0.01
Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models 0.07
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
A route for cerebrospinal fluid flow through leptomeningeal arterial–venous overlaps enables macromolecule and fluid shunting 0.08
1 0.05
The brain neurovascular epigenome and its association with dementia 0.05
2 1.88
Oxytocin neurons drive melanocortin circuit maturation via vesicle release during a neonatal critical period 0.88
Zebrafish fast muscle contractions avoid the mammalian requirement for voltage-gated Na+ channels 1.00
1 0.06
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial) 0.06
5 1.97
Competition between glycine and GABAA receptors for gephyrin controls their equilibrium populations at inhibitory synapses 0.82
Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson’s disease iPSC model 0.09
Higher-order interactions in neuronal function: From genes to ionic currents in biophysical models 0.14
Excitatory glycine receptors control ventral hippocampus synaptic plasticity and anxiety-related behaviors 0.88
Imaging a concussion and the ensuing immune response at the blood–brain barrier 0.04
1 0.06
Net Water Uptake at CT Predicts the Treatment Effect of Thrombectomy for Low ASPECTS Stroke. 0.06
2 0.29
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes 0.09
Norepinephrine changes behavioral state through astroglial purinergic signaling 0.20
6 2.88
Preventing neuropathy and improving anticancer chemotherapy with a carbazole-based compound 0.78
Structure of the Huntingtin F-actin complex reveals its role in cytoskeleton organization 0.44
Voice identity invariance by anterior temporal lobe neurons 1.00
Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates 0.58
Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration 0.01
Capturing structural intermediates in an animal-like cryptochrome photoreceptor by time-resolved crystallography 0.07
3 0.66
Skin thermal dynamics and hypothalamic thermosensitivity dissociate REM sleep and cataplexy in narcolepsy 0.23
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis 0.29
Immune signatures link myelin oligodendrocyte glycoprotein antibody–associated disease to other autoantibody-mediated conditions 0.14
1 0.95
Optochemical profiling of NMDAR molecular diversity at synaptic and extrasynaptic sites. 0.95
1 0.50
Persistent Orbital Magnetism from Light-Induced Attosecond Charge Migration in Linear Molecules 0.50
2 0.67
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial 0.06
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial 0.60
4 1.96
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study 0.75
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial 1.00
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.09
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial 0.12
2 0.08
Asundexian for Secondary Stroke Prevention 0.04
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1 0.05
1 1.00
Health trajectories of patients with amyotrophic lateral sclerosis before and after initiation of non-invasive ventilation: a French nationwide database analysis 1.00

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.